Status:
UNKNOWN
COVID-19 Pandemic and Worldwide Organ Procurement
Lead Sponsor:
Paris Translational Research Center for Organ Transplantation
Collaborating Sponsors:
Agence de La Biomédecine
Eurotransplant
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
End-stage organ failure is estimated to affect more than 4 to 6 million persons worldwide. In 2018, transplant systems across the globe enabled around 150,000 patients to benefit from a kidney, heart,...
Eligibility Criteria
Inclusion
- All organs procured for transplantation and transplanted during the observation period. These include kidney, lung, liver, heart, and combined transplantations.
Exclusion
- None
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
230000 Patients enrolled
Trial Details
Trial ID
NCT04416256
Start Date
February 1 2020
End Date
February 1 2022
Last Update
June 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Paris Transplant Group
Paris, France, 75015